DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Alphagan (Brimonidine Tartrate) - Indications and Dosage

 
 



INDICATIONS AND USAGE

ALPHAGAN® P is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

DOSAGE AND ADMINISTRATION

The recommended dose is one drop of ALPHAGAN® P in the affected eye(s) three times daily, approximately 8 hours apart.

ALPHAGAN® P ophthalmic solution may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic product is being used, the products should be administered at least 5 minutes apart.

HOW SUPPLIED

ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.15% is supplied sterile in opaque teal LDPE plastic bottles and tips with purple high impact polystyrene (HIPS) caps as follows:

5 mL in 10 mL bottle         NDC 0023-9177-05

10 mL in 10 mL bottle       NDC 0023-9177-10

15 mL in 15 mL bottle       NDC 0023-9177-15

NOTE:    Store at 15°-25°C (59°-77°F).

Rx Only

® Marks owned by Allergan, Inc.

U.S. Pat. 5,424,078; 5,736,165; 6,194,415; 6,248,741; 6,465,464; 6,562,873; 6,627,210; 6,641,834; 6,673,337

ALLERGAN

© 2003 Allergan, Inc

Irvine, CA 92612, U.S.A.

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012